Polyrizon Ltd. — Investor Relations & Filings
Polyrizon Ltd. is a clinical-stage biotechnology company focused on the development and commercialization of innovative intranasal products. The company's core technology is based on proprietary hydrogels delivered as nasal sprays. Polyrizon is advancing two primary platforms: Capture & Contain™ (C&C), which creates a protective bioadhesive gel barrier in the nasal cavity to block airborne pathogens and allergens, and Trap & Target™ (T&T), a system designed for the targeted intranasal delivery of therapeutic drugs. The company's pipeline includes candidates for preventative treatments, such as allergy blockers, and drug delivery systems with potential applications for the central nervous system (CNS).
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - Polyrizon Ltd. (0001893645) (Filer) | 2026-05-04 | English | |
| 6-K - Polyrizon Ltd. (0001893645) (Filer) | 2026-04-27 | English | |
| 6-K - Polyrizon Ltd. (0001893645) (Filer) | 2026-04-08 | English | |
| 424B5 - Polyrizon Ltd. (0001893645) (Filer) | 2026-04-08 | English | |
| 20-F/A - Polyrizon Ltd. (0001893645) (Filer) | 2026-03-27 | English | |
| 20-F - Polyrizon Ltd. (0001893645) (Filer) | 2026-03-25 | English |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Polyrizon Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35346/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35346 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35346 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35346 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35346}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Polyrizon Ltd. (id: 35346)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.